Rhode Island-based biotechnology company MultiCell Technologies Inc. is teaming up with Maxim Biotech Inc. under cooperative research and development agreement to develop products for studying liver stem cells and liver cancer.
MultiCell (OTC: MCET), based in Woonsocket, owns exclusive rights to two issued U.S. patents, one U.S. patent application and a handful of corresponding foreign patents and patent applications regarding the isolation and differentiation of liver stem cells.
No financial details of the agreement with South San Francisco-based Maxim Biotech were disclosed. The deal will initially focus on creating a family of research reagent tool kits which can be used to isolate liver stem cells and help to determine liver stem cell gene function and their encoded proteins.
Continue reading ‘MultiCell teams with Maxim Biotech to study live stem cells and cancer’
Maybe you can find something interesting in the following sponsored links:
Incoming search terms:
in the stem cell factory at “latest stem cells news” mht, multicell technologies news 2011, cancer stem cell lab, mcet liver regeneration, liver regeneration news mcet 2012, nih stem cell reseaech maxim, news about the latest technologies in biotech in 2011, new york liver stem cell research, new developments liver cancer, multicell technologies news, multicell technologies and maxim biotech, multicell technologies, multicell tech and university health, multicell patents, multicell live, multicell and stem cells and cerebral palsy, patents for dental stem cell extraction and cultivation, patents mcet, three stem cell cancer research news liver, stem liver liver regeneration hepatocarcinoma, stem cells cerebral palsy study, stem cell products and liver cancer, stem cell liver regeneration latest news 2011, stem cell liver lab Switzerland, stem cell latest news liver, stem cell biotech cancer nyc, ri stem cell treatment liver cancer, resveratrol ductal cell, resveratrol bile duct cancer, resveratrol and bile duct cancer, primary liver cancer stem cell, multi cell technology news, mcet news uk, LATEST NEWS FOR MCET STEM CELL, annick goutal cancer, hans clevers liver, fat cell biotech firms, cancer stem cell product, California biotech liver regeneration, california biotech companies liver, california based biotech stem cell breakthrough, biotechnology in cerebral palsey, biotechnology cell cancer 2011, biotech week resveratrol.
